Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis

Cancer Research

Volumn 71, Issue 20, 2011, Pages 6535-6546

  Cho, Sung Gook ^a,c   Wang, Ying ^a   Rodriguez, Melissa ^a   Tan, Kunrong ^a   Zhang, Wenzheng ^b   Luo, Jian ^d   Li, Dali ^d   Liu, Mingyao ^a,c,d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KISSPEPTIN 10; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HETEROZYGOSITY; IN VITRO STUDY; IN VIVO STUDY; KISS1R GENE; LATENT PERIOD; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BREAST; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HAPLOINSUFFICIENCY; HUMANS; KISSPEPTINS; LUNG NEOPLASMS; MALE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; RECEPTORS, G-PROTEIN-COUPLED; RHO GTP-BINDING PROTEINS;

EID: 80054020596     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-0329     Document Type: Article

References (50)

1. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS, Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003;349:1614-27. (Pubitemid 37303886)
2. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003;100:10972-6. (Pubitemid 37140137)
3. Funes S, Hedrick JA, Vassileva G, Markowitz L, Abbondanzo S, Golovko A, et al. The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun 2003;312:1357-63. (Pubitemid 37490966)
4. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001;411:613-7. (Pubitemid 32531412)
5. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996;88:1731-7. (Pubitemid 26405010)
6. Lee JH, Welch DR. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 1997;57:2384-7. (Pubitemid 27255895)
7. Nash KT, Phadke PA, Navenot JM, Hurst DR, Accavitti-Loper MA, Sztul E, et al. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. J Natl Cancer Inst 2007;99:309-21. (Pubitemid 47078727)
8. Stafford LJ, Xia C, Ma W, Cai Y, Liu M. Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor. Cancer Res 2002;62:5399-404.
9. Mitchell DC, Stafford LJ, Li D, Bar-Eli M, Liu M. Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130. Oncogene 2007;26:1739-47. (Pubitemid 46426193)
10. Mead EJ, Maguire JJ, Kuc RE, Davenport AP. Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol 2007;151:1143-53. (Pubitemid 47255895)
11. -/-mice. Endocrinology 2007;148:4927-36.
12. Nash KT, Welch DR. The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Front Biosci 2006;11:647-59. (Pubitemid 43258169)
13. Mitchell DC, Abdelrahim M, Weng J, Stafford LJ, Safe S, Bar-Eli M, et al. Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1. J Biol Chem 2006;281:51-8. (Pubitemid 43671162)
14. Tsuji K, Kawauchi S, Saito S, Furuya T, Ikemoto K, Nakao M, et al. Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues. BMC Cancer 2010;10:15.
15. Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Rougé C, et al. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Br J Cancer 2006;95:1439-47. (Pubitemid 44760099)
16. Argos M, Kibriya MG, Jasmine F, Olopade OI, Su T, Hibshoosh H, et al. Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays. Cancer Genet Cytogenet 2008;182:69-74. (Pubitemid 351491323)
17. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schröck E, et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 1995;55:5415-23.
18. Forozan F, Mahlamäki EH, Monni O, Chen Y, Veldman R, Jiang Y, et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000;60:4519-25. (Pubitemid 32103634)
19. Negrini M, Sabbioni S, Possati L, Rattan S, Corallini A, Barbanti-Brodano G, et al. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res 1994;54:1331-6.
20. Bilanges B, Varrault A, Basyuk E, Rodriguez C, Mazumdar A, Pantaloni C, et al. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene 1999;18:3979-88. (Pubitemid 29361336)
21. Cingoz S, Altungoz O, Canda T, Saydam S, Aksakoglu G, Sakizli M. DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors. Cancer Genet Cytogenet 2003;145:108-14. (Pubitemid 36993740)
22. Prentice LM, Klausen C, Kalloger S, Köbel M, McKinney S, Santos JL, et al. Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma. BMC Med 2007;5:33.
23. Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, et al. Large isoformof MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res 2008;10:R22.
24. Stark AM, Tongers K, Maass N, Mehdorn HM, Held-Feindt J. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. J Cancer Res Clin Oncol 2005;131:191-8. (Pubitemid 40175014)
25. Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007;7:659-72. (Pubitemid 47327411)
26. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003;163:2113-26. (Pubitemid 37310040)
27. Navenot JM, Fujii N, Peiper SC. Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis. Mol Pharmacol 2009;75:1300-6.
28. Cho SG, Li D, Stafford LJ, Luo J, Rodriguez-Villanueva M, Wang Y, et al. KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J Cell Biochem 2009;107:1139-49.
29. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 2009;119:252-66.
30. Rodriguez-Viciana P, Collins C, Fried M. Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. Proc Natl Acad Sci U S A 2006;103:19290-5. (Pubitemid 46026025)
31. Ueyama T, Sakoda T, Kawashima S, Hiraoka E, Hirata K, Akita H, et al. Activated RhoA stimulates c-fos gene expression in myocardial cells. Circ Res 1997;81:672-8. (Pubitemid 27467201)
32. Hill CS, Wynne J, Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 1995;81:1159-70.
33. Fromm C, Coso OA, Montaner S, Xu N, Gutkind JS. The small GTP-binding protein Rho links G protein-coupled receptors and Galpha12 to the serum response element and to cellular transformation. Proc Natl Acad Sci U S A 1997;94:10098-103.
34. Wacker JL, Feller DB, Tang XB, Defino MC, Namkung Y, Lyssand JS, et al. Disease-causing mutation in GPR54 reveals the importance of the second intracellular loop for class A G-protein-coupled receptor function. J Biol Chem 2008;283:31068-78.
35. Guo X, Stafford LJ, Bryan B, Xia C, Ma W, Wu X, et al. A Rac/Cdc42- specific exchange factor, GEFT, induces cell proliferation, transformation, and migration. J Biol Chem 2003;278:13207-15.
36. Lutz S, Shankaranarayanan A, Coco C, Ridilla M, Nance MR, Vettel C, et al. Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs. Science 2007;318:1923-7.
37. Lutz S, Freichel-Blomquist A, Yang Y, Rümenapp U, Jakobs KH, Schmidt M, et al. The guanine nucleotide exchange factor p63Rho-GEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J Biol Chem 2005;280:11134-9. (Pubitemid 40418419)
38. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensusmatches in nucleotide sequence data. Nucleic Acids Res 1995;23:4878-84. (Pubitemid 3008389)
39. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009;457:599-602.
40. Lamba S, Felicioni L, Buttitta F, Bleeker FE, Malatesta S, Corbo V, et al. Mutational profile of GNAQQ209 in human tumors. PLoS One 2009;4:e6833.
41. Zhao X, Lu L, Pokhriyal N, Ma H, Duan L, Lin S, et al. Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells. Cancer Res 2009;69:483-91.
42. Hogan C, Dupré-Crochet S, Norman M, Kajita M, Zimmermann C, Pelling AE, et al. Characterization of the interface between normal and transformed epithelial cells. Nat Cell Biol 2009;11:460-7.
43. Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY, et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 2010;12:457-67.
44. Shoji S, Tang XY, Umemura S, Itoh J, Takekoshi S, Shima M, et al. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Eur Urol 2009;55:441-9.
45. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer 2009;9:108-22.
46. Bhalla US. Understanding complex signaling networks through models and metaphors. Prog Biophys Mol Biol 2003;81:45-65. (Pubitemid 35436610)
47. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, Jonkers J, et al. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 2007;39:759-69. (Pubitemid 46848585)
48. Varticovski L, Hollingshead MG, Robles AI, Wu X, Cherry J, Munroe DJ, et al. Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clin Cancer Res 2007;13:2168-77. (Pubitemid 46649887)
49. Qiu TH, Chandramouli GV, Hunter KW, Alkharouf NW, Green JE, Liu ET. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res 2004;64:5973-81. (Pubitemid 39129393)
50. Cho SG, Yi Z, Pang X, Yi T, Wang Y, Luo J, et al. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res 2009;69:7062-70.